Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 262

    1.

    Accelerated fractionation radiotherapy and late intensification with 2 intra-arterial cisplatin infusions for locally advanced head and neck squamous cell carcinoma.

    Yu KH, Yu SC, Hui EP, Kam MK, Vlantis AC, Yuen E, Chan AT.

    Head Neck. 2009 Nov 2. [Epub ahead of print]PMID: 19885925 [PubMed - as supplied by publisher]Related articles

    2.

    Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.

    Wee JT, Anderson BO, Corry J, D'Cruz A, Soo KC, Qian CN, Chua DT, Hicks RJ, Goh CH, Khoo JB, Ong SC, Forastiere AA, Chan AT.

    Lancet Oncol. 2009 Nov;10(11):1086-92.PMID: 19880062 [PubMed - in process]Related articles

    3.

    Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.

    Hong B, Lui VW, Hui EP, Lu Y, Leung HS, Wong EY, Cheng SH, Ng MH, Mills GB, Chan AT.

    Biochem Pharmacol. 2009 Oct 30. [Epub ahead of print]PMID: 19879857 [PubMed - as supplied by publisher]Related articles

    4.

    Cucurbitacin I Elicits Anoikis-sensitization, Inhibits Cellular Invasion and In Vivo Tumor Formation Ability of Nasopharyngeal Carcinoma Cells.

    Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y, Chan JP, Hong B, Ho K, Cheung CS, Tsang CM, Tsao SW, Chan AT.

    Carcinogenesis. 2009 Oct 20. [Epub ahead of print]PMID: 19843642 [PubMed - as supplied by publisher]Related articles

    5.

    Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response.

    Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, Chen H, Lo KW, Tao Q, Chan AT.

    Invest New Drugs. 2009 Sep 16. [Epub ahead of print]PMID: 19756373 [PubMed - as supplied by publisher]Related articles

    6.

    Interaction of molecular markers and physical activity on mortality in patients with colon cancer.

    Meyerhardt JA, Ogino S, Kirkner GJ, Chan AT, Wolpin B, Ng K, Nosho K, Shima K, Giovannucci EL, Loda M, Fuchs CS.

    Clin Cancer Res. 2009 Sep 15;15(18):5931-6. Epub 2009 Sep 1.PMID: 19723652 [PubMed - in process]Related articles

    7.

    Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.

    Ng K, Wolpin BM, Meyerhardt JA, Wu K, Chan AT, Hollis BW, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS.

    Br J Cancer. 2009 Sep 15;101(6):916-23. Epub 2009 Aug 18.PMID: 19690551 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aspirin use and survival after diagnosis of colorectal cancer.

    Chan AT, Ogino S, Fuchs CS.

    JAMA. 2009 Aug 12;302(6):649-58.PMID: 19671906 [PubMed - indexed for MEDLINE]Related articles

    9.

    Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?

    Chan SL, Chan AT, Yeo W.

    Future Oncol. 2009 Aug;5(6):889-99.PMID: 19663737 [PubMed - in process]Related articles

    10.

    STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.

    Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, Ma BB, Hui EP, Chan AS, Tsang CM, Tsao SW, Grandis JR, Chan AT.

    Int J Cancer. 2009 Oct 15;125(8):1884-93.PMID: 19588483 [PubMed - indexed for MEDLINE]Related articles

    11.

    Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

    Chan AT, Felip E; ESMO Guidelines Working Group.

    Ann Oncol. 2009 May;20 Suppl 4:123-5. No abstract available. PMID: 19454431 [PubMed - in process]Related articles

    12.

    A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells.

    Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW, Chan AT.

    Cancer Lett. 2009 Jun 25. [Epub ahead of print]PMID: 19560263 [PubMed - as supplied by publisher]Related articles

    13.

    Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms.

    Ma BB, Hui EP, Wong SC, Tung SY, Yuen KK, King A, Chan SL, Leung SF, Kam MK, Yu BK, Zee B, Chan AT.

    Ann Oncol. 2009 Nov;20(11):1854-9. Epub 2009 Jun 23.PMID: 19549713 [PubMed - in process]Related articles

    14.

    A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

    Ogino S, Nosho K, Baba Y, Kure S, Shima K, Irahara N, Toyoda S, Chen L, Kirkner GJ, Wolpin BM, Chan AT, Giovannucci EL, Fuchs CS.

    Am J Gastroenterol. 2009 Aug;104(8):2047-56. Epub 2009 Jun 9.PMID: 19513025 [PubMed - indexed for MEDLINE]Related articles

    15.

    CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.

    Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, Luo B, Zhang Q, Mok TS, Zheng W, Qiu X, Srivastava G, Yu J, Sung JJ, Chan AT, Ma D, Tao Q, Han W.

    Cancer Res. 2009 Jun 15;69(12):5194-201. Epub 2009 Jun 9.PMID: 19509237 [PubMed - indexed for MEDLINE]Related articles

    16.

    The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines.

    Ma BB, Lui VW, Hui EP, Lau CP, Ho K, Ng MH, Cheng SH, Tsao SW, Chan AT.

    Invest New Drugs. 2009 May 27. [Epub ahead of print]PMID: 19471857 [PubMed - as supplied by publisher]Related articles

    17.

    Advanced proteomic technologies for cancer biomarker discovery.

    Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT.

    Expert Rev Proteomics. 2009 Apr;6(2):123-34. Review.PMID: 19385940 [PubMed - indexed for MEDLINE]Related articles

    18.

    Update in antiepidermal growth factor receptor therapy in the management of metastatic colorectal cancer.

    Loong HH, Ma BB, Chan AT.

    J Oncol. 2009;2009:967920. Epub 2009 Apr 9.PMID: 19365583 [PubMed - in process]Related articlesFree article

    19.

    Accomplishments in 2007 in the management of hepatobiliary cancers.

    Chan AT, Kishi Y, Chan SL, Vauthey JN.

    Gastrointest Cancer Res. 2008 May;2(3 Suppl):S25-31.PMID: 19352465 [PubMed - in process]Related articlesFree article

    20.

    Thoracic spinal gout mimicking metastasis.

    Chan AT, Leung JL, Sy AN, Wong WW, Lau KY, Ngai WT, Tang VW.

    Hong Kong Med J. 2009 Apr;15(2):143-5.PMID: 19342742 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Body mass index and Barrett's oesophagus in women.

    Jacobson BC, Chan AT, Giovannucci EL, Fuchs CS.

    Gut. 2009 Nov;58(11):1460-6. Epub 2009 Mar 30.PMID: 19336423 [PubMed - in process]Related articles

    22.

    Infection and cancer: biology, therapeutics and prevention.

    Ma BB, Chan AT.

    Future Oncol. 2009 Mar;5(2):149-51. No abstract available. PMID: 19284372 [PubMed - indexed for MEDLINE]Related articles

    23.

    ABO blood group and the risk of pancreatic cancer.

    Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS.

    J Natl Cancer Inst. 2009 Mar 18;101(6):424-31. Epub 2009 Mar 10.PMID: 19276450 [PubMed - indexed for MEDLINE]Related articles

    24.

    PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.

    Ogino S, Nosho K, Kirkner GJ, Shima K, Irahara N, Kure S, Chan AT, Engelman JA, Kraft P, Cantley LC, Giovannucci EL, Fuchs CS.

    J Clin Oncol. 2009 Mar 20;27(9):1477-84. Epub 2009 Feb 23.PMID: 19237633 [PubMed - indexed for MEDLINE]Related articles

    25.

    Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.

    Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawk ET, Bertagnolli MM.

    Gastroenterology. 2009 Jun;136(7):2127-2136.e1. Epub 2009 Feb 21.PMID: 19233181 [PubMed - indexed for MEDLINE]Related articles

    26.

    Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.

    Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT.

    Clin Cancer Res. 2009 Feb 1;15(3):1005-12.PMID: 19188172 [PubMed - indexed for MEDLINE]Related articles

    27.

    The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines.

    Ma BB, Sung F, Tao Q, Poon FF, Lui VW, Yeo W, Chan SL, Chan AT.

    Invest New Drugs. 2009 Jan 27. [Epub ahead of print]PMID: 19172229 [PubMed - as supplied by publisher]Related articles

    28.

    A broadly adaptive array of dose-constraint templates for planning of intensity-modulated radiation therapy for advanced T-stage nasopharyngeal carcinoma.

    Chau RM, Leung SF, Kam MK, Cheung KY, Kwan WH, Yu KH, Chiu KW, Cheung ML, Chan AT.

    Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):21-8. Epub 2009 Jan 24.PMID: 19171440 [PubMed - indexed for MEDLINE]Related articles

    29.

    DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.

    Ying J, Poon FF, Yu J, Geng H, Wong AH, Qiu GH, Goh HK, Rha SY, Tian L, Chan AT, Sung JJ, Tao Q.

    Br J Cancer. 2009 Feb 24;100(4):663-9. Epub 2009 Jan 20.PMID: 19156137 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.

    Ogino S, Kirkner GJ, Nosho K, Irahara N, Kure S, Shima K, Hazra A, Chan AT, Dehari R, Giovannucci EL, Fuchs CS.

    Clin Cancer Res. 2008 Dec 15;14(24):8221-7.PMID: 19088039 [PubMed - indexed for MEDLINE]Related articles

    31.

    Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.

    Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS.

    J Clin Oncol. 2009 Jan 10;27(2):176-85. Epub 2008 Dec 8.PMID: 19064975 [PubMed - indexed for MEDLINE]Related articles

    32.

    Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.

    Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC, Chan AT.

    J Clin Oncol. 2009 Jan 10;27(2):242-9. Epub 2008 Dec 8.PMID: 19064973 [PubMed - indexed for MEDLINE]Related articles

    33.

    New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.

    Chan SL, Mo FK, Johnson PJ, Hui EP, Ma BB, Ho WM, Lam KC, Chan AT, Mok TS, Yeo W.

    J Clin Oncol. 2009 Jan 20;27(3):446-52. Epub 2008 Dec 8.PMID: 19064965 [PubMed - indexed for MEDLINE]Related articles

    34.

    A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

    Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS.

    J Natl Cancer Inst. 2008 Dec 3;100(23):1734-8. Epub 2008 Nov 25.PMID: 19033568 [PubMed - indexed for MEDLINE]Related articles

    35.

    Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer.

    Loong HH, Ma BB, Chan AT.

    Hematol Oncol Clin North Am. 2008 Dec;22(6):1267-78, x. Review.PMID: 19010273 [PubMed - indexed for MEDLINE]Related articles

    36.

    TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.

    Wong N, Yeo W, Wong WL, Wong NL, Chan KY, Mo FK, Koh J, Chan SL, Chan AT, Lai PB, Ching AK, Tong JH, Ng HK, Johnson PJ, To KF.

    Int J Cancer. 2009 Feb 1;124(3):644-52.PMID: 19003983 [PubMed - indexed for MEDLINE]Related articles

    37.

    Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.

    Nosho K, Kawasaki T, Chan AT, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.

    Histopathology. 2008 Nov;53(5):588-98.PMID: 18983468 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.

    Hui EP, Sung FL, Yu BK, Wong CS, Ma BB, Lin X, Chan A, Wong WL, Chan AT.

    Clin Cancer Res. 2008 Nov 1;14(21):7080-7.PMID: 18981006 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Cohort study of fatty acid synthase expression and patient survival in colon cancer.

    Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, Giovannucci EL, Loda M, Fuchs CS.

    J Clin Oncol. 2008 Dec 10;26(35):5713-20. Epub 2008 Oct 27.PMID: 18955444 [PubMed - indexed for MEDLINE]Related articles

    40.

    Size ratio effects on interparticle interactions and phase behavior of microsphere-nanoparticle mixtures.

    Chan AT, Lewis JA.

    Langmuir. 2008 Oct 21;24(20):11399-405. Epub 2008 Sep 24.PMID: 18816017 [PubMed - indexed for MEDLINE]Related articles

    41.

    OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.

    Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, Loyo M, Chan AT, Srivastava G, Tsao GS, Sellar GC, Sung JJ, Sidransky D, Tao Q.

    PLoS One. 2008 Aug 20;3(8):e2990.PMID: 18714356 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients.

    Chan KC, Leung SF, Yeung SW, Chan AT, Lo YM.

    Clin Cancer Res. 2008 Aug 1;14(15):4809-13.PMID: 18676752 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.

    Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Röcken C, Ebert MP, Chan AT, Sung JJ.

    Hepatology. 2008 Aug;48(2):508-18.PMID: 18666234 [PubMed - indexed for MEDLINE]Related articles

    44.

    Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients.

    Chan KC, Leung SF, Yeung SW, Chan AT, Lo YM.

    Clin Cancer Res. 2008 Jul 1;14(13):4141-5.PMID: 18593992 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

    Wong CS, Wong VW, Chan CM, Ma BB, Hui EP, Wong MC, Lam MY, Au TC, Chan WH, Cheuk W, Chan AT.

    Oncol Rep. 2008 Jul;20(1):89-98.PMID: 18575723 [PubMed - indexed for MEDLINE]Related articles

    46.

    A novel application of plasma and cerebrospinal fluid level of epstein barr virus DNA in the diagnosis of leptomeningeal metastasis from nasopharyngeal carcinoma. A case report.

    Ma AT, Ma BB, Teo PM, Chan AT.

    Oncology. 2008;74(1-2):119-22. Epub 2008 Jun 12. Review.PMID: 18547967 [PubMed - indexed for MEDLINE]Related articles

    47.

    Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk.

    Berndt SI, Potter JD, Hazra A, Yeager M, Thomas G, Makar KW, Welch R, Cross AJ, Huang WY, Schoen RE, Giovannucci E, Chan AT, Chanock SJ, Peters U, Hunter DJ, Hayes RB.

    Hum Mol Genet. 2008 Sep 1;17(17):2665-72. Epub 2008 Jun 4.PMID: 18535017 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.

    Ma BB, Hui EP, Chan AT.

    Cancer Sci. 2008 Jul;99(7):1311-8. Epub 2008 May 21. Review.PMID: 18498420 [PubMed - indexed for MEDLINE]Related articles

    49.

    Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.

    Hazra A, Fuchs CS, Chan AT, Giovannucci EL, Hunter DJ.

    Cancer Causes Control. 2008 Nov;19(9):975-80. Epub 2008 May 14.PMID: 18478343 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.

    Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, Chan AT, Sung JJ, Tao Q.

    Oncogene. 2008 Sep 4;27(39):5267-76. Epub 2008 May 12.PMID: 18469857 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...